12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-Suspension Delivery Technology in Patients with COPD

被引：0
|
作者：
Ferguson, G. T. [1 ]
Rabe, K. F. [2 ,3 ,4 ]
Bourne, E. [5 ]
Ballal, S. [6 ]
DeAngelis, K. [5 ]
Aurivillius, M. [7 ]
Reisner, C. [6 ,8 ]
Dorinsky, P. [5 ]
机构：
[1] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[2] LungenClin Grosshansdorf, Grosshansdorf, Germany
[3] Christian Albrechts Univ Kiel, Airway Res Ctr North, Grosshansdorf, Germany
[4] German Ctr Lung Res DZL, Grosshansdorf, Germany
[5] Pearl, Durham, NC USA
[6] Pearl, Morristown, NJ USA
[7] AstraZeneca Gothenburg, Molndal, Sweden
[8] AstraZeneca, Morristown, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3351
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD
    Ferguson, G. T.
    Rabe, K. F.
    Bourne, E.
    Ballal, S.
    DeAngelis, K.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    PNEUMOLOGIE, 2020, 74 : S43 - S44
  • [2] Bone Mineral Density and Ocular Safety After 52 Weeks' Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Using Co-Suspension Delivery Technology in COPD
    Kerwin, E. M.
    Ferguson, G. T.
    Mo, M.
    DeAngelis, K.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
    Chen, Rongchang
    Zhong, Nanshan
    Wang, Hao-Yan
    Zhao, Li
    Mei, Xiaodong
    Qin, Zhiqiang
    Huang, Juan
    Assam, Pryseley N.
    Maes, Andrea
    Siddiqui, Shahid
    Martin, Ubaldo J.
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 43 - 56
  • [4] Effect Of Glycopyrrolate/formoterol Fumarate Fixed-Dose Combination Metered Dose Inhaler (gff Mdi) Delivered By Novel Co-Suspension™ Delivery Technology On Daily Symptoms In Patients With COPD
    Martinez, F. J.
    Fabbri, L. M.
    Ferguson, G. T.
    Orevillo, C.
    Darken, P.
    Martin, U. J.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD
    Dunn, Leonard J.
    Kerwin, Edward M.
    DeAngelis, Kiernan
    Darken, Patrick
    Gillen, Michael
    Dorinsky, Paul
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 60
  • [6] EFFICACY AND SAFETY OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE METERED DOSE INHALER (GFF MDI) DELIVERED USING CO-SUSPENSION DELIVERY TECHNOLOGY IN CHINESE PATIENTS WITH COPD
    Zhong, Nanshan
    Chen, Rongchang
    Wang, Hao-Yan
    Zhao, Li
    Mei, Xiaodong
    Qin, Zhiqiang
    Assam, Pryseley N.
    Maes, Andrea
    Martin, Ubaldo J.
    Reisner, Colin
    RESPIROLOGY, 2018, 23 : 81 - 81
  • [7] Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD
    Ichinose, Masakazu
    Fukushima, Yasushi
    Inoue, Yoshikazu
    Hataji, Osamu
    Ferguson, Gary T.
    Rabe, Klaus F.
    Hayashi, Nobuya
    Okada, Hiroshi
    Takikawa, Mami
    Bourne, Eric
    Ballal, Shaila
    DeAngelis, Kiernan
    Aurivillius, Magnus
    Reisner, Colin
    Dorinsky, Paul
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2993 - 3002
  • [8] Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
    Martinez, Fernando J.
    Rabe, Klaus F.
    Ferguson, Gary T.
    Fabbri, Leonardo M.
    Rennard, Stephen
    Feldman, Gregory J.
    Sethi, Sanjay
    Spangenthal, Selwyn
    Gottschlich, Gregory M.
    Rodriguez-Roisin, Roberto
    Arora, Samir
    Siler, Thomas M.
    Siddiqui, Shahid
    Darken, Patrick
    Fischer, Tracy
    Maes, Andrea
    Golden, Michael
    Orevillo, Chad
    Reisner, Colin
    CHEST, 2017, 151 (02) : 340 - 357
  • [9] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study
    Ichinose, Masakazu
    Fukushima, Yasushi
    Inoue, Yoshikazu
    Hataji, Osamu
    Ferguson, Gary T.
    Rabe, Klaus F.
    Hayashi, Nobuya
    Okada, Hiroshi
    Takikawa, Mami
    Bourne, Eric
    Ballal, Shaila
    DeAngelis, Kiernan
    Aurivillius, Magnus
    Dorinsky, Paul
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2979 - 2991
  • [10] Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial
    Rabe, K. F.
    Martinez, F. J.
    Singh, D.
    McLaren, J.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345